In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

In this series of live, 1-hour CME/CE-certified meetings, expert faculty members will present an overview of CRPC and the current treatment landscape with an emphasis on interactive, case vignettes to highlight choice of therapy, toxicity management, and key issues in the multidisciplinary manage

The goal of this activity is to improve participants’ competence in providing optimal care for patients with ovarian and cervical cancer as well as their knowledge of emerging clinical trial data and current guideline and expert recommendations.

This symposium has been designed to bring up-to-date scientific information to clinicians involved in the care of patients with thoracic malignancies, including Lung Cancer, Mesothelioma, and Esophageal Cancer.

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances.

The NCCN 20^th Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care profess

The NCCN 20^th Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care profess